Drug Research
Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs
Regeneron Pharmaceuticals, Inc. and Sanofi have restructured their global Immuno-oncology Discovery and Development Agreement for new immuno-oncology cancer treatments. The 2015...
Articles
Global Developments in Real-World Evidence
Real-world evidence (RWE) and real-world data (RWD) can ‘generate insights about a medicine’s effectiveness, safety and associated costs,1 and due to the emergence of...
News
‘Enjoyable forms’ to see major contract services growth in 2019
Sirio Pharma Co. Ltd (SIRIO) – the global nutraceutical contract development, innovation and manufacturing organization (CDiMO) – forecasts considerable worldwide growth in outsourced manufacturing...
Drug Research
GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay for Non-Alcoholic SteatoHepatitis
LabCorp, a leading global life sciences company, and GENFIT , a biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting...
News
FDA grants fast track designation to ImmusanT’s vaccine for celiac disease
Clinical-stage company ImmusanT’s therapeutic vaccine candidate Nexvax2 has been granted fast track designation by the US FDA. ImmusanT uses its trademarked...
Drug Research
Propanc Biopharma Commences Drug Discovery Research Collaboration
Propanc Biopharma, Inc , a clinical stage biopharmaceutical company focused on development of new and proprietary treatments for cancer patients suffering from solid tumors...
Drug Research
Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read